会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Ligation enhancement
    • 连接增强
    • US08697408B2
    • 2014-04-15
    • US13464548
    • 2012-05-04
    • Rebecca KuceraThomas C. Evans, Jr.
    • Rebecca KuceraThomas C. Evans, Jr.
    • C12N9/00C12P19/34C12Q1/68C40B50/06
    • C12N15/10C12N9/93C12N15/66C12P19/34C12Q1/6832Y02P20/52C12Q2521/501C12Q2527/127C12Q2527/137
    • Compositions and methods are provided for enhancing enzymatic ligation between nucleic acid fragments that relies on one or more small molecule enhancers having a size of less than 1000 daltons. For example, enhancement of ligation efficiencies are observed for double-stranded nucleic acid fragments that are blunt-ended, have a single nucleotide overhang at the ligation end, or have staggered ends compared to ligation under similar conditions in the absence of the one or more small molecule ligation enhancer. The use of small molecule enhancers for ligating nucleic acids results in an increased number of transformed host cells after transformation with the ligated molecules. This enhancement can be observed with chemically transformed host cells and with host cells transformed by electroporation.
    • 提供了组合物和方法,用于增强依赖于一种或多种尺寸小于1000道尔顿的小分子增强剂的核酸片段之间的酶连接。 例如,对于平端的双链核酸片段,在连接末端具有单个核苷酸突出端,或者在不存在一个或多个相似条件的相似条件下与连接相比具有交错末端,观察到连接效率的增强 小分子连接增强子。 使用小分子增强子连接核酸导致用连接的分子转化后转化的宿主细胞数量增加。 可以通过化学转化的宿主细胞和通过电穿孔转化的宿主细胞来观察这种增强。
    • 4. 发明授权
    • Modified DNA cleavage enzymes and methods for use
    • 修饰的DNA切割酶和使用方法
    • US07851192B2
    • 2010-12-14
    • US10585964
    • 2004-11-22
    • Chudi GuanSanjay KumarRebecca Kucera
    • Chudi GuanSanjay KumarRebecca Kucera
    • C12N9/16C12Q1/44C12Q1/68C07K14/00C12N15/00C12N1/21C12P21/00C07H21/00
    • C12N9/22
    • Compositions and methods are provided that relate to a modified DNA cleaving enzyme having at least 35% amino acid sequence identity with T7 Endo I. The modified enzyme includes two catalytic centers separated by a β-bridge where the β-bridge contains at least one mutation having an effect of altering enzyme cleavage activity compared to the unmodified enzyme. Activities associated with the modified DNA cleaving enzyme that can be modulated in different reaction conditions include at least one of: (a) non-sequence specific nicking activity; (b) cleaving the second strand of a duplex DNA at a preexisting nick site to produce a linear duplex with a single strand overhang; (c) non-sequence specific DNA cleavage; (d) cleaving DNA flanking a mismatch; and (e) cleavage at a cruciform structure in a DNA duplex.
    • 提供了与T7 Endo I具有至少35%的氨基酸序列同一性的修饰的DNA切割酶的组合物和方法。修饰的酶包括两个由“桥”分开的催化中心,其中“桥”至少包含 一个突变与未修饰的酶相比具有改变酶裂解活性的作用。 与可以在不同反应条件下调节的修饰的DNA切割酶相关的活性包括以下至少一个:(a)非序列特异性切口活性; (b)在预先存在的切口位点切割双链体DNA的第二链以产生具有单链突出端的线性双链体; (c)非序列特异性DNA切割; (d)切断位于不对称侧翼的DNA; 和(e)在DNA双链体中的十字形结构处的切割。
    • 5. 发明申请
    • Modified dna cleavage enzymes and methods for use (as amended by isa)
    • 修饰的dna切割酶和使用方法(由isa修改)
    • US20070042379A1
    • 2007-02-22
    • US10585964
    • 2004-11-22
    • Chudi GuanSanjay KumarRebecca Kucera
    • Chudi GuanSanjay KumarRebecca Kucera
    • C12Q1/68C07H21/04C12P21/06C12N9/22
    • C12N9/22
    • Compositions and methods are provided that relate to a modified DNA cleaving enzyme having at least 35% amino acid sequence identity with T7 Endo I. The modified enzyme includes two catalytic centers separated by a β-bridge where the β-bridge contains at least one mutation having an effect of altering enzyme cleavage activity compared to the unmodified enzyme. Activities associated with the modified DNA cleaving enzyme that can be modulated in different reaction conditions include at least one of: (a) non-sequence specific nicking activity; (b) cleaving the second strand of a duplex DNA at a preexisting nick site to produce a linear duplex with a single strand overhang; (c) non-sequence specific DNA cleavage; (d) cleaving DNA flanking a mismatch; and (e) cleavage at a cruciform structure in a DNA duplex.
    • 提供了与T7 Endo I具有至少35%氨基酸序列同一性的修饰的DNA切割酶的组合物和方法。修饰的酶包括由β桥分开的两个催化中心,其中β-桥含有至少一个突变 与未修饰的酶相比具有改变酶裂解活性的作用。 与可以在不同反应条件下调节的修饰的DNA切割酶相关的活性包括以下至少一个:(a)非序列特异性切口活性; (b)在预先存在的切口位点切割双链体DNA的第二链以产生具有单链突出端的线性双链体; (c)非序列特异性DNA切割; (d)切断位于不对称侧翼的DNA; 和(e)在DNA双链体中的十字形结构处的切割。
    • 10. 发明申请
    • Ligation Enhancement
    • 连接增强
    • US20120283144A1
    • 2012-11-08
    • US13464548
    • 2012-05-04
    • Rebecca KuceraThomas C. Evans, JR.
    • Rebecca KuceraThomas C. Evans, JR.
    • C40B50/06C12N9/12C12P19/34C12N9/00
    • C12N15/10C12N9/93C12N15/66C12P19/34C12Q1/6832Y02P20/52C12Q2521/501C12Q2527/127C12Q2527/137
    • Compositions and methods are provided for enhancing enzymatic ligation between nucleic acid fragments that relies on one or more small molecule enhancers having a size of less than 1000 daltons. For example, enhancement of ligation efficiencies are observed for double-stranded nucleic acid fragments that are blunt-ended, have a single nucleotide overhang at the ligation end, or have staggered ends compared to ligation under similar conditions in the absence of the one or more small molecule ligation enhancer. The use of small molecule enhancers for ligating nucleic acids results in an increased number of transformed host cells after transformation with the ligated molecules. This enhancement can be observed with chemically transformed host cells and with host cells transformed by electroporation.
    • 提供了组合物和方法,用于增强依赖于一种或多种尺寸小于1000道尔顿的小分子增强剂的核酸片段之间的酶连接。 例如,对于平端的双链核酸片段,在连接末端具有单个核苷酸突出端,或者在不存在一个或多个相似条件的相似条件下与连接相比,具有交错末端,观察到连接效率的增强 小分子连接增强子。 使用小分子增强子连接核酸导致用连接的分子转化后转化的宿主细胞数量增加。 可以通过化学转化的宿主细胞和通过电穿孔转化的宿主细胞来观察这种增强。